Iteos Therapeutics Inc (ITOS)
Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -134,414 | -112,642 | 96,652 | 214,521 | -38,033 |
| Depreciation Amortization | -10,280 | -9,336 | -925 | 603 | 535 |
| Accounts receivable | -3,407 | -2,385 | 3,988 | -3,344 | 5,033 |
| Accounts payable and accrued liabilities | -2,446 | 3,036 | 2,761 | 2,280 | 1,677 |
| Other Working Capital | 18,635 | -8,799 | -228,481 | 284,222 | 9,330 |
| Other Operating Activity | 33,731 | 26,370 | 14,812 | 14,858 | -3,718 |
| Operating Cash Flow | $-98,181 | $-103,756 | $-111,193 | $513,140 | $-25,176 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -25 | -99 | -120 | -61 | -21 |
| PPE Investments | -1,633 | -2,966 | -938 | -1,181 | -356 |
| Purchase Of Investment | -520,801 | -290,541 | -445,004 | N/A | N/A |
| Sale Of Investment | 391,308 | 366,264 | N/A | N/A | N/A |
| Investing Cash Flow | $-131,151 | $72,658 | $-446,062 | $-1,242 | $-377 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,059 | 716 | 4,046 |
| Common Stock Issued | 122,718 | 1,113 | 925 | 2,943 | 214,315 |
| Other Financing Activity | -477 | 0 | 0 | 0 | 121,978 |
| Financing Cash Flow | $122,241 | $1,113 | $1,984 | $3,659 | $340,339 |
| Exchange Rate Effect | -1,930 | -3,602 | -8,526 | -3,176 | 1,678 |
| Beginning Cash Position | 251,451 | 285,038 | 848,835 | 336,454 | 19,990 |
| End Cash Position | 142,430 | 251,451 | 285,038 | 848,835 | 336,454 |
| Net Cash Flow | $-109,021 | $-33,587 | $-563,797 | $512,381 | $316,464 |
| Free Cash Flow | |||||
| Operating Cash Flow | -98,181 | -103,756 | -111,193 | 513,140 | -25,176 |
| Capital Expenditure | -1,633 | -2,966 | -938 | -1,181 | -356 |
| Free Cash Flow | -99,814 | -106,722 | -112,131 | 511,959 | -25,532 |